TG Therapeutics
TGTX
TGTX
303 hedge funds and large institutions have $2.36B invested in TG Therapeutics in 2024 Q3 according to their latest regulatory filings, with 96 funds opening new positions, 93 increasing their positions, 72 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
19% more funds holding
Funds holding: 254 → 303 (+49)
4.83% more ownership
Funds ownership: 60.36% → 65.2% (+4.8%)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Holders
303
Holding in Top 10
5
Calls
$70.9M
Puts
$46.8M
Top Buyers
| 1 | +$247M | |
| 2 | +$56.1M | |
| 3 | +$39.7M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$26.8M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
+$17M |
Top Sellers
| 1 | -$40.6M | |
| 2 | -$36.5M | |
| 3 | -$35.1M | |
| 4 |
Millennium Management
New York
|
-$33.8M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$26.8M |